Delivery Order SPE2DB22D1106-SPE2DB25FEMB3

Award Date 5/5/25
Potential Completion Date 5/6/25
Potential Value $8.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,758.33, is for the supply of 4,561,941,446 units of Concerta ER 18 mg tablets. The award has an ultimate completion date of August 25, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,367.60, is for the delivery of 4,566,554,868 units of the drug Concerta ER 18 mg tablets. The contract has an ultimate completion date of November 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,835,376 units of the drug Concerta ER 18 mg tablet, with a total ceiling value of $9,466.39. The contract has a performance period ending on September 17, 2024. Amerisourcebergen is the prime contractor for this award and there is no set-aside designation. This contract is likely part of a...
This $10,116.20 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,560 units of Concerta ER 18 mg tablets. The contract has an ultimate completion date of February 24, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the supply of 4,565,618,675 units of the prescription medication Concerta ER 27 mg tablets, with a firm fixed price ceiling value of $8,007.96. The award date is August 28, 2024, and the ultimate completion date is August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONCERTA ER 18 MG tablets. The contract has a ceiling value of $9,392.93 and a period of performance through September 24, 2024. The contract is not set-aside for a specific business type. This delivery order appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,212,098 units of Concerta ER 18 mg tablets, with a ceiling value of $6,220.26 and an ultimate completion date of October 24, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,086.63 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,725,450 units of the drug Concerta ER 18 mg tablet. The contract has an ultimate completion date of September 10, 2024 and was awarded on September 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,470,642 units of the prescription medication CONCERTA ER 18 MG TABLET 100S. The contract has a firm fixed price of $39,443.04 and an ultimate completion date of August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which enables the...
This is a $6,454.41 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of CONCERTA ER 18 MG TABLET 100S. The contract is a firm fixed price arrangement with a period of performance through July 30, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEMB3
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,149,789 units of the drug Concerta ER 18 mg tablet, with a total ceiling value of $8,524.41. The contract has a period of performance through May 6, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to military healthcare programs. The contract is not set aside and is open to full and open competition.

Generated 8/4/25, 9:50 AM